Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liskonum 450mg modified-release tablets
0402030K0BDAAAG
|
Liskonum | Lithium carbonate | Central Nervous System | 1,243 |
|
Venaxx XL 150mg capsules
0403040W0BLABAE
|
Venaxx | Venlafaxine | Central Nervous System | 1,242 |
|
Meflynate XL 40mg capsules
0404000M0BNADAW
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 1,240 |
|
NiQuitin 14mg patches
0410020B0BDABAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,235 |
|
Efexor XL 225mg capsules
0403040W0BBAFAT
|
Efexor | Venlafaxine | Central Nervous System | 1,233 |
|
Paracetamol 250mg suppositories
0407010H0AACBCB
|
Paracetamol | Paracetamol | Central Nervous System | 1,229 |
|
Adartrel 500microgram tablets
0409010H0BCAAAH
|
Adartrel | Ropinirole hydrochloride | Central Nervous System | 1,222 |
|
Piracetam 1.2g tablets
0409030P0AAACAC
|
Piracetam | Piracetam | Central Nervous System | 1,218 |
|
Seroquel XL 50mg tablets
0402010ABBBAHAV
|
Seroquel | Quetiapine | Central Nervous System | 1,216 |
|
Diazepam 2mg/5ml oral suspension
0401020K0AACICI
|
Diazepam | Diazepam | Central Nervous System | 1,215 |
|
NiQuitin Clear 14mg patches
0410020B0BDAEAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,213 |
|
Bupeaze 70micrograms/hour transdermal patches
0407020B0BIACAG
|
Bupeaze | Buprenorphine | Central Nervous System | 1,210 |
|
Episenta 150mg modified-release capsules
0408010W0BIABBQ
|
Episenta | Sodium valproate | Central Nervous System | 1,210 |
|
Vimpat 100mg tablets
0408010AHBBABAB
|
Vimpat | Lacosamide | Central Nervous System | 1,209 |
|
Haloperidol decanoate 100mg/1ml inj ampoules
0402020T0AAABAB
|
Haloperidol decanoate | Haloperidol decanoate | Central Nervous System | 1,208 |
|
Depixol 20mg/1ml solution for injection ampoules
0402020G0BBAAAA
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1,206 |
|
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets
0407020AFAAACAC
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,206 |
|
OxyContin 40mg modified-release tablets
0407020ADBCACAH
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 1,206 |
|
DHC Continus 120mg tablets
0407020G0BBACAF
|
DHC Continus | Dihydrocodeine tartrate | Central Nervous System | 1,205 |
|
Nicorette QuickMist 1mg/dose mouthspray cool berry
0410020B0BBBEBW
|
Nicorette | Nicotine | Central Nervous System | 1,204 |
|
Delmosart 18mg modified-release tablets
0404000M0BJAAAM
|
Delmosart | Methylphenidate hydrochloride | Central Nervous System | 1,201 |
|
Reltebon 10mg modified-release tablets
0407020ADBKABAF
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,191 |
|
Maxitram SR 200mg capsules
040702040BPADAJ
|
Maxitram | Tramadol hydrochloride | Central Nervous System | 1,189 |
|
Cymbalta 30mg gastro-resistant capsules
0403040Y0BBAAAA
|
Cymbalta (Antidepressant) | Duloxetine hydrochloride | Central Nervous System | 1,188 |
|
Nicorette invisi 10mg/16hours patches
0410020B0BBATAT
|
Nicorette | Nicotine | Central Nervous System | 1,182 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.